26 related articles for article (PubMed ID: 1701614)
1. Software for screening to assess risk of Down's syndrome.
Reynolds TM
BMJ; 1991 Apr; 302(6782):965. PubMed ID: 1827745
[No Abstract] [Full Text] [Related]
2. The utility of fetal biometry as an adjunct to the multiple-marker screening test for Down syndrome.
Owen J; Wenstrom KD; Hardin JM; Boots LR; Hsu CC; Cosper PC; DuBard MB
Am J Obstet Gynecol; 1994 Oct; 171(4):1041-6. PubMed ID: 7524323
[TBL] [Abstract][Full Text] [Related]
3. Triple marker (alpha-fetoprotein, unconjugated estriol, human chorionic gonadotropin) versus alpha-fetoprotein plus free-beta subunit in second-trimester maternal serum screening for fetal Down syndrome: a prospective comparison study.
Kellner LH; Weiner Z; Weiss RR; Neuer M; Martin GM; Mueenuddin M; Bombard A
Am J Obstet Gynecol; 1995 Oct; 173(4):1306-9. PubMed ID: 7485343
[TBL] [Abstract][Full Text] [Related]
4. Prenatal screening for Down's syndrome with use of maternal serum markers.
Haddow JE; Palomaki GE; Knight GJ; Williams J; Pulkkinen A; Canick JA; Saller DN; Bowers GB
N Engl J Med; 1992 Aug; 327(9):588-93. PubMed ID: 1379344
[TBL] [Abstract][Full Text] [Related]
5. Role of prenatal ultrasonography in women with positive screen for Down syndrome on the basis of maternal serum markers.
Nyberg DA; Luthy DA; Cheng EY; Sheley RC; Resta RG; Williams MA
Am J Obstet Gynecol; 1995 Oct; 173(4):1030-5. PubMed ID: 7485289
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome.
Mooney RA; Peterson CJ; French CA; Saller DN; Arvan DA
Obstet Gynecol; 1994 Aug; 84(2):298-303. PubMed ID: 7518896
[TBL] [Abstract][Full Text] [Related]
7. Potential prenatal predictions of Down syndrome: a statistical analysis.
O'Brien WF; Knuppel RA; Torres C; Sternlicht D
Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 1):1796-8. PubMed ID: 1701614
[TBL] [Abstract][Full Text] [Related]
8. [Prenatal diagnosis of trisomy 21].
Massé J; Forest JC
Ann Biol Clin (Paris); 1990; 48(8):536-40. PubMed ID: 1705107
[TBL] [Abstract][Full Text] [Related]
9. Down syndrome: prenatal risk assessment and diagnosis.
Newberger DS
Am Fam Physician; 2000 Aug; 62(4):825-32, 837-8. PubMed ID: 10969860
[TBL] [Abstract][Full Text] [Related]
10. Prenatal cytogenetic screening.
Simpson JL
Ultrasound Obstet Gynecol; 1995 Jan; 5(1):3-5. PubMed ID: 7531607
[No Abstract] [Full Text] [Related]
11. Antenatal screening for aneuploidy.
Chitty LS
Curr Opin Obstet Gynecol; 1998 Apr; 10(2):91-6. PubMed ID: 9551302
[TBL] [Abstract][Full Text] [Related]
12. Combined serum and ultrasound screening for detection of fetal aneuploidy.
Bahado-Singh R; Cheng CC; Matta P; Small M; Mahoney MJ
Semin Perinatol; 2003 Apr; 27(2):145-51. PubMed ID: 12769200
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
